Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

“Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” says Katie. “I was forced to try to schedule meetings, lunches and other ...

Ulcerative colitis has several available treatments, including one from Pfizer. FDA approval of a new drug gives Pfizer an opportunity to expand its reach in this market with a molecule whose ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...

News and commentary from the world of gastroenterology and hepatology ...

The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. This is an exciting time to think about ...

Mirikizumab treatment is safe and efficacious for ulcerative colitis up to 152 weeks in those with and without previous biologic therapy failure. Mirikizumab treatment for 152 weeks is associated with ...

While complementary therapies won’t treat the underlying cause of ulcerative colitis (UC), they can help you manage your symptoms and improve your overall quality of life. Ulcerative colitis (UC) is ...

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...

Join us at the Promenade at Sunset Walk to raise awareness and funds for those fighting and living with Crohn’s disease and ulcerative colitis (collectively known as inflammatory bowel disease or IBD) ...